EN-MSC/TERT352-B2025-04-03T09:29:05+00:00

Endometrium

EN-MSC/TERT352-B

Evercyte’s EN-MSC/TERT352-B cell line has been developed from endometrium (endometriosis tissue) -derived mesenchymal stromal cells (MSC). The cells can be grown without limitations, show typical markers and functions of MSCs and therefore represent a valuable model for studying processes such as differentiation, inflammation, tissue homeostasis and repair. In recent years, evidence has accumulated that the potency of mesenchymal stromal cells at least in part is mediated by secreted extracellular vesicles (EVs). EN-MSC/TERT352-B cell line has been established under conditions that will allow the production of EVs for clinical applications.

from

€ 1700,-
EN-MSC/TERT352-B
Cat#: CHT-060-0352-B

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

P-MSC/TERT308

placental amniotic membrane-derived MSCs for the production of clinical grade-EVs

all about our
EV cell factories

MSCs for production of clinical grade extracellular vesicles

Tissue targeting: recombinant EVs

engineering of CD81 on extracellular vesicles to target specific cell surface proteins

Related Services

contact us if you are interested in engineering of extracellular vesicles to target specific cell surface proteins

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Related Products

mesenchymal stromal cells for production of clinical grade extracellular vesicles

Related Services

production and characterization of extracellualr vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

from

€ 1700,--

EN-MSC/TERT352-B
Cat#: CHT-060-0352-B

 

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Go to Top